| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.044 | 0.8 |